Publications

  1. Dalvin LA, Garcia MD, Salomao DR, Iezzi R, Barkmeier AJ. Necrotizing Subconjunctival Granulomata and Intraoperative Use of Topical GenTeal Gel. Ophthalmology 2016 Jun 17 Epub 2016 June 17
    View PubMed
  2. Bakri SJ, Omar AF, Iezzi R, Kapoor KG. EVALUATION OF MULTIPLE DEXAMETHASONE INTRAVITREAL IMPLANTS IN PATIENTS WITH MACULAR EDEMA ASSOCIATED WITH RETINAL VEIN OCCLUSION. Retina 2016 Mar; 36 (3):552-7
    View PubMed
  3. Bakri SJ, Omar AF, Iezzi R, Kapoor KG. Evaluation of multiple dexamethasone intravitreal implants in patients with macular edema associated with retinal vein occlusion Retina-the Journal Of Retinal And Vitreous Diseases 2016 Mar; 36 (3):552-7
  4. Iezzi R. Regenerative ophthalmology: Technologic and pharmacologic approaches to restoring sight via retinal prosthesis. Clin Pharmacol Ther 2016 Jan; 99 (1):33-5 Epub 2015 Nov 23
    View PubMed
  5. Ghodasra DH, Chen A, Arevalo JF, Birch DG, Branham K, Coley B, Dagnelie G, de Juan E, Devenyi RG, Dorn JD, Fisher A, Geruschat DR, Gregori NZ, Greenberg RJ, Hahn P, Ho AC, Howson A, Huang SS, Iezzi R, Khan N, Lam BL, Lim JI, Locke KG, Markowitz M, Ripley AM, Rankin M, Schimitzek H, Tripp F, Weiland JD, Yan J, Zacks DN, Jayasundera KT. Worldwide Argus II implantation: recommendations to optimize patient outcomes. BMC Ophthalmol 2016; 16 (1):52 Epub 2016 May 06
    View PubMed
  6. Veverka KK, AbouChehade JE, Iezzi R Jr, Pulido JS. NONINVASIVE GRADING OF RADIATION RETINOPATHY: The Use of Optical Coherence Tomography Angiography. Retina 2015 Nov; 35 (11):2400-10
    View PubMed
  7. Cunha-Vaz J, Ashton P, Iezzi R, Campochiaro P, Dugel PU, Holz FG, Weber M, Danis RP, Kuppermann BD, Bailey C, Billman K, Kapik B, Kane F, Green K, FAME Study Group. Sustained delivery fluocinolone acetonide vitreous implants: long-term benefit in patients with chronic diabetic macular edema. Ophthalmology. 2014 Oct; 121(10):1892-903. Epub 2014 Jun 14.
    View PubMed
  8. Treger JS, Priest MF, Iezzi R, Bezanilla F. Real-time imaging of electrical signals with an infrared FDA-approved dye. Biophys J. 2014 Sep 16; 107(6):L09-12.
    View PubMed
  9. Kim BJ, Ying GS, Huang J, Levy NE, Maguire MG, Iezzi Raymond MD *. Sporadic visual acuity loss in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT). Am J Ophthalmol. 2014 Jul; 158(1):128-135.e10. Epub 2014 Apr 13
    View PubMed
  10. Hagstrom SA, Ying GS, Pauer GJ, Sturgill-Short GM, Huang J, Maguire MG, Martin DF, Iezzi Raymond MD. VEGFA and VEGFR2 gene polymorphisms and response to anti-vascular endothelial growth factor therapy: comparison of age-related macular degeneration treatments trials (CATT). JAMA Ophthalmol. 2014 May; 132(5):521-7.
    View PubMed
  11. Iezzi R. Facedown positioning is not necessary in idiopathic macular hole repair change from current standard of care reduces morbidity and improves patient experience. Retina Today. 2014; (Jan/Feb):58-60.
  12. Iezzi R, Kapoor KG. No face-down positioning and broad internal limiting membrane peeling in the surgical repair of idiopathic macular holes. Ophthalmology. 2013 Oct; 120(10):1998-2003. Epub 2013 Jul 24.
    View PubMed
  13. Jaffe GJ, Martin DF, Toth CA, Daniel E, Maguire MG, Ying GS, Grunwald JE, Huang J. Macular morphology and visual acuity in the comparison of age-related macular degeneration treatments trials. Ophthalmology. 2013 Sep; 120(9):1860-70. Epub 2013 May 1
    View PubMed
  14. Danis RP, Domalpally A, Chew EY, Clemons TE, Armstrong J, SanGiovanni JP, Ferris FL 3rd. Methods and reproducibility of grading optimized digital color fundus photographs in the Age-Related Eye Disease Study 2 (AREDS2 Report Number 2). Invest Ophthalmol Vis Sci. 2013 Jul; 54(7):4548-54. Epub 2013 Jul 8
    View PubMed
  15. Kapoor KG, Shultz RW, Iezzi R. Vitreous pillow for sustained-release intravitreous drug delivery implants. Ophthalmic Surg Lasers Imaging Retina. 2013 Mar-Apr; 44(2):181-2.
    View PubMed
  16. Iezzi R, Kannan RM. Dendrimers as vehicles for intravitreal drug delivery: These nanoparticles can selectively localize within activated retinal microglia, ferrying drugs to fight inflammation. Retina Today. 2013; (July/August):59-60.
  17. The AREDS2 Research Group, Writing Committee, Chew E, Clemons T, SanGiovanni JP, Danis R, Domalpally A, McBee W, Sperduto R, Ferris, F, AREDS2 Research Group, The Age-Related Eye Disease Study 2 (AREDS2). Study Design and Baseline Characteristics (AREDS2 Report Number 1). Ophthalmology. 26 July 2012.
  18. Comparison of Age-related Macular Degeneration Treatments Trials (CATT) Research Group, Martin DF, Maguire MG, Fine SL, Ying GS, Jaffe GJ, Grunwald JE, Toth C, Redford M, Ferris FL 3rd. Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results. (CATT). Ophthalmology. 2012 Jul; 119(7):1388-1398.
    View PubMed
  19. Iezzi R, Guru BR, Glybina IV, Mishra MK, Kennedy A, Kannan RM. Dendrimer-based targeted intravitreal therapy for sustained attenuation of neuroinflammation in retinal degeneration. Biomaterials. 2012 Jan; 33(3):979-88. Epub 2011 Nov 01.
    View PubMed
  20. Kung S, Ahuja Y, Iezzi R, Sampson SM. Posterior vitreous detachment and retinal tear after repetitive transcranial magnetic stimulation. Brain Stimul 2011 Oct; 4 (4):218-21 Epub 2011 Sept 06
    View PubMed
  21. Li Y, Tu H, Iezzi R, Finlayson P, Xu Y. Development of individually-addressable parylene microtube arrays. J Micromech Microeng. August 2011.
  22. CATT Research Group, Martin DF, Maguire MG, Ying GS, Grunwald JE, Fine SL, Jaffe GJ. Ranibizumab and bevacizumab for neovascular age-related macular degeneration. N Engl J Med 2011 May 19; 364 (20):1897-908 Epub 2011 Apr 28
    View PubMed
  23. Campochiaro PA, Brown DM, Pearson A, Ciulla T, Boyer D, Holz FG, Tolentino M, Gupta A, Duarte L, Madreperla S, Gonder J, Kapik B, Billman K, Kane FE. Long-term benefit of sustained-delivery fluocinolone acetonide vitreous inserts for diabetic macular edema. Ophthalmology. 2011 Apr; 118(4):626-635.e2.
    View PubMed
  24. Kinnick TR, Mullins RF, Dev S, Leys M, Mackey DA, Kay CN, Lam BL, Fishman GA, Traboulsi E, Iezzi R, Stone EM. Autosomal recessive vitelliform macular dystrophy in a large cohort of vitelliform macular dystrophy patients. Retina. 2011 Mar; 31(3):581-95.
    View PubMed
  25. Glybina IV, Kennedy A, Ashton P, Abrams GW, Iezzi R. Intravitreous delivery of the corticosteroid fluocinolone acetonide attenuates retinal degeneration in S334ter-4 rats. Invest Ophthalmol Vis Sci. 2010 Aug; 51(8):4243-52. Epub 2010 Mar 10.
    View PubMed
  26. Finlayson PG, Iezzi R. Glutamate stimulation of retinal ganglion cells in normal and s334ter-4 rat retinas: a candidate for a neurotransmitter-based retinal prosthesis. Invest Ophthalmol Vis Sci. 2010 Jul; 51(7):3619-28. Epub 2010 Feb 17.
    View PubMed
  27. Singh CN, Iezzi R, Mahmoud TH. Intraocular pressure instability after 23-gauge vitrectomy. Retina. 2010 Apr; 30(4):629-34.
    View PubMed
  28. Scott IU, Oden NL, VanVeldhuisen PC, Ip MS, Blodi BA, Antoszyk AN. SCORE Study Report 7: incidence of intravitreal silicone oil droplets associated with staked-on vs luer cone syringe design. Am J Ophthalmol. 2009 Nov; 148(5):725-732.e7. Epub 2009 Aug 11.
    View PubMed
  29. Glybina IV, Kennedy A, Ashton P, Abrams GW, Iezzi R. Photoreceptor neuroprotection in RCS rats via low-dose intravitreal sustained-delivery of fluocinolone acetonide. Invest Ophthalmol Vis Sci. 2009 Oct; 50(10):4847-57. Epub 2009 Apr 30.
    View PubMed
  30. Scott IU, Ip MS, VanVeldhuisen PC, Oden NL, Blodi BA, Fisher M, Chan CK, Gonzalez VH, Singerman LJ, Tolentino M. A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular Edema secondary to branch retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 6. Occlusion (SCORE) study report 6. Arch Ophthalmol. 2009 Sep; 127(9):1115-28.
    View PubMed
  31. Ip MS, Scott IU, VanVeldhuisen PC, Oden NL, Blodi BA, Fisher M, Singerman LJ, Tolentino M, Chan CK, Gonzalez VH. A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 5. Occlusion (SCORE) study report 5. Arch Ophthalmol. 2009 Sep; 127(9):1101-14.
    View PubMed
  32. Elfar SD, Cottaris NP, Iezzi R, Abrams GW. A cortical (V1) neurophysiological recording model for assessing the efficacy of retinal visual prostheses. J Neurosci Methods. 2009 Jun 15; 180(2):195-207. Epub 2009 Mar 10.
    View PubMed
  33. Iezzi R, Finlayson P, Xu Y, Katragadda R. Microfluidic neurotransmiter-based neural interfaces for retinal prosthesis. Conf Proc IEEE Eng Med Biol Soc. 2009; 2009:4563-5.
    View PubMed
  34. Berkowitz BA, Gradianu M, Schafer S, Jin Y, Porchia A, Iezzi R, Roberts R. Ionic dysregulatory phenotyping of pathologic retinal thinning with manganese-enhanced MRI. Invest Ophthalmol Vis Sci. 2008 Jul; 49(7):3178-84. Epub 2008 Mar 24.
    View PubMed
  35. Kent TL, Glybina IV, Abrams GW, Iezzi R. Chronic intravitreous infusion of ciliary neurotrophic factor modulates electrical retinal stimulation thresholds in the RCS rat. Invest Ophthalmol Vis Sci. 2008 Jan; 49(1):372-9.
    View PubMed
  36. Abowd MC, Black EH, Iezzi R, Budev H. Choroidal melanoma with massive extrascleral extension in a young black man. Ophthal Plast Reconstr Surg. 2005 May; 21(3):240-2.
    View PubMed
  37. Frank RN, Schulz L, Abe K, Iezzi R. Temporal variation in diabetic macular edema measured by optical coherence tomography. Ophthalmology. 2004 Feb; 111(2):211-7.
    View PubMed
  38. Garcia-Valenzuela E, Abdelsalam A, Eliott D, Pons M, Iezzi R, Puklin JE, McDermott ML, Abrams GW. Reduced need for corneal epithelial debridement during vitreo-retinal surgery using two different viscous surface lubricants. Am J Ophthalmol. 2003 Dec; 136(6):1062-6.
    View PubMed
  39. Romero JM, Finger PT, Rosen RB, Iezzi R. Three-dimensional ultrasound for the measurement of choroidal melanomas. Arch Ophthalmol. 2001 Sep; 119(9):1275-82.
    View PubMed
  40. Marigo FA, Finger PT, McCormick SA, Iezzi R, Esaki K, Ishikawa H, Liebmann JM, Ritch R. Iris and ciliary body melanomas: ultrasound biomicroscopy with histopathologic correlation. Arch Ophthalmol. 2000 Nov; 118(11):1515-21.
    View PubMed
  41. Barr D, Kupersmith M, Turbin R, Yang S, Iezzi R. Synkinesis following diabetic third nerve palsy. Arch Ophthalmol. 2000 Jan; 118(1):132-4.
    View PubMed
  42. Finger PT, Iezzi R, Esteveo ML, Szechter A, Rosen RB, Berson A. Diode-light transillumination for ophthalmic plaque localization around juxtapapillary choroidal melanomas. Int J Radiat Oncol Biol Phys. 1999 Jul 1; 44(4):887-90.
    View PubMed
  43. Finger PT, Iezzi R, Romero JM, Rosen RB, Szechter A, Hegde H. Plaque-mounted diode-light transillumination for localization around intraocular tumors. Arch Ophthalmol. 1999 Feb; 117(2):179-83.
    View PubMed
  44. Marigo FA, Finger PT, McCormick SA, Iezzi R, Esaki K, Ishikawa H, Seedor J, Liebmann JM, Ritch R. Anterior segment implantation cysts. Ultrasound biomicroscopy with histopathologic correlation. Arch Ophthalmol. 1998 Dec; 116(12):1569-75.
    View PubMed
  45. Romero JM, Finger PT, Iezzi R, Rosen RB, Cocker RS. Three-dimensional ultrasonography of choroidal melanoma: extrascleral extension. Am J Ophthalmol. 1998 Dec; 126(6):842-4.
    View PubMed
  46. Finger PT, Romero JM, Rosen RB, Iezzi R, Emery R, Berson A. Three-dimensional ultrasonography of choroidal melanoma: localization of radioactive eye plaques. Arch Ophthalmol. 1998 Mar; 116(3):305-12.
    View PubMed
  47. Iezzi R, Rosen RB, Tello C, Liebmann J, Walsh JB, Ritch R. Personal computer-based 3-dimensional ultrasound biomicroscopy of the anterior segment. Arch Ophthalmol. 1996 May; 114(5):520-4.
    View PubMed